Effects of blood components of preoperative autologous blood donation on functions of myelopoietic stem cells

References

• Sugimoto T, Hashimoto M, Hayakawa I, et al. Alterations in HbA1c resulting from the donation of autologous blood for elective surgery in patients with diabetes mellitus. Blood Trans. 2014 Jan;12(Suppl. 1):209–213. DOI:10.2450/2013.0271-12.
   Google Scholar
• Zhou J. A review of the application of autologous blood transfusion. Braz J Med Biol Res. 2016 Aug 1;49(9):e5493. DOI:10.1590/1414-431x20165493
   PubMed Web of Science ®Google Scholar
• Sharma S, Boston SE, Kotlowski J, et al. Preoperative autologous blood donation and transfusion in dogs undergoing elective surgical oncology procedures with high risk of hemorrhage. Vet Surg. 2021;50(3):607–614. DOI:10.1111/vsu.13598
   PubMed Web of Science ®Google Scholar
• Mendelson A, Frenette PS. Hematopoietic stem cell niche maintenance during homeostasis and regeneration. Nat Med. 2014;20(8):833–846. DOI:10.1038/nm.3647
   PubMed Web of Science ®Google Scholar
• Vranken NPA, Weerwind PW, Barenbrug PJC, et al. The role of patient’s profile and allogeneic blood transfusion in development of post-cardiac surgery infections: a retrospective study. Int Cardiovasc Thorac Surg. 2014;19:232–238. DOI:10.1093/icvts/ivu096
   PubMed Web of Science ®Google Scholar
• Santos AA, Sousa AG, Piotto RF, et al. Mortality risk is dose-dependent on the number of packed red blood cell transfused after coronary artery bypass graft. Rev Bras Cir Cardiovasc. 2013;28(4):509–517. DOI:10.5935/1678-9741.20130083
   PubMedGoogle Scholar
• Murphy GJ, Reeves BC, Rogers CA, et al. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007;116:2544–2552. DOI:10.1161/CIRCULATIONAHA.107.698977
   PubMed Web of Science ®Google Scholar
• Tian X, Yang F, Wu Y. Advances in research and application of hematopoietic stem cells. Chin J Cell Biol. 2019;41(6):1003–1011.
   Google Scholar
• Yamashita M, Nitta E, Suda T. Regulation of hematopoietic stem cell integrity through p53 and its related factors. Ann N Y Acad Sci. 2016;1370(1):45–54. DOI:10.1111/nyas.12986
   PubMedGoogle Scholar
• Ito K, Ito K. Hematopoietic stem cell fate through metabolic control. Exp Hematol. 2018 Aug;64:1–11. DOI:10.1016/j.exphem.2018.05.005
   PubMed Web of Science ®Google Scholar
• Adelman ER, Figueroa ME. Human hematopoiesis: aging and leukemogenic risk. Curr Opin Hematol. 2021;28(1):57–63. DOI:10.1097/MOH.0000000000000622
   PubMed Web of Science ®Google Scholar
• Cakouros D, Gronthos S. Epigenetic regulation of bone marrow stem cell aging: revealing epigenetic signatures associated with hematopoietic and mesenchymal stem cell aging. Aging Dis. 2019;10(1):174–189. DOI:10.14336/AD.2017.1213
   PubMed Web of Science ®Google Scholar
• Pinho S, Frenette PS. Haematopoietic stem cell activity and interactions with the niche. Nat Rev Mol Cell Biol. 2019 May;20(5):303–320. DOI:10.1038/s41580-019-0103-9.
   PubMed Web of Science ®Google Scholar
• Mohamad Kamal NS, Safuan S, Shamsuddin S, et al. Aging of the cells: insight into cellular senescence and detection methods. Eur J Cell Biol 2020;99(6):151108. DOI:10.1016/j.ejcb.2020.151108
   PubMed Web of Science ®Google Scholar
• Lin CS, Ning H, Lin G, et al. Is CD34 truly a negative marker for mesenchymal stem cells? Cytotherapy. 2012;14(10):1159–1163. DOI:10.3109/14653249.2012.729817
   PubMed Web of Science ®Google Scholar
• Pala C, Mumcuoglu H, Kurnaz F, et al. Changes in CD34 + cell count in peripheral blood after whole blood donation. Transfus Apher Sci. 2013;49(2):259–262. DOI:10.1016/j.transci.2013.04.038
   PubMed Web of Science ®Google Scholar
• Schultz MB, Sinclair DA. When stem cells grow old: phenotypes and mechanisms of stem cell aging. Development. 2016;143(1):3–14. DOI:10.1242/dev.130633
   PubMed Web of Science ®Google Scholar
• Rossi DJ, Bryder D, Seita J, et al. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature. 2007;447(7145):725–729. DOI:10.1038/nature05862
   PubMed Web of Science ®Google Scholar
• Dumble M, Moore L, Chambers SM, et al. The impact of altered p53 dosage on hematopoietic stem cell dynamics during aging. Blood. 2007 Feb 15;109(4):1736–1742. DOI:10.1182/blood-2006-03-010413.
   PubMed Web of Science ®Google Scholar
• Janzen V, Forkert R, Fleming HE, et al. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature. 2006;443(7110):421–426. DOI:10.1038/nature05159
   PubMed Web of Science ®Google Scholar
• Van Os R, Kamminga LM, Ausema A, et al. A limited role for p21Cip1/Waf1 in maintaining normal hematopoietic stem cell functioning. Stem Cells. 2007;25(4):836–843. DOI:10.1634/stemcells.2006-0631
   PubMed Web of Science ®Google Scholar
• Almeida M, O’Brien CA. Basic biology of skeletal aging: role of stress response pathways. J Gerontol A Biol Sci Med Sci. 2013;68(10):1197–1208. DOI:10.1093/gerona/glt079
   PubMed Web of Science ®Google Scholar
• An R, Yi W, Ju Z. Progress in hematopoietic stem cell ageing research. Progr Biochem Biophys. 2014;41(3):238–246. DOI:10.3724/SP.J.1206.2014.00008
   Web of Science ®Google Scholar
• Koralkova P, Van Solinge WW. Rare hereditary red blood cell enzymopathies associated with hemolytic anemia–pathophysiology, clinical aspects, and laboratory diagnosis. Int J Lab Hematol. 2014;36(3):388–397. DOI:10.1111/ijlh.12223
   PubMed Web of Science ®Google Scholar
• Simak J, Gelderman MP. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev. 2006;20(1):1–26. DOI:10.1016/j.tmrv.2005.08.001
   PubMed Web of Science ®Google Scholar
• Angelillo-Scherrer A. Leukocyte-derived microparticles in vascular homeostasis. Circ Res. 2012;110(2):356–369. DOI:10.1161/CIRCRESAHA.110.233403
   PubMed Web of Science ®Google Scholar